XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock And Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Parent [Member]
Noncontrolling Interest [Member]
Class A Common Stock [Member]
Class A Common Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Class B Common Stock [Member]
Class B Common Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Preferred Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Balance (in shares) at Dec. 31, 2020               358,110   3  
Balance at Dec. 31, 2020 $ 26,351.5 $ 21,189.1 $ 4,995.9 $ 134.9 $ 26,319.9            
Balance at Dec. 31, 2020           $ 31.6          
Less: net (income) loss attributable to non-controlling interests (0.5)         (0.5)          
Net Income Attributable to CME Group 2,011.2   2,011.2   2,011.2            
Net Income 2,011.7                    
Other comprehensive income (loss), net of tax (97.6)     (97.6) (97.6)            
Dividends, Cash (969.7)   (969.7)   (969.7)            
Purchase of noncontrolling interest (52.0) (19.9)     (19.9) 32.1          
Exercise of stock options, shares               102      
Exercise of stock options 5.5 5.5     5.5            
Vesting of issued restricted Class A common stock, shares               329      
Vesting of issued restricted Class A common stock (31.2) (31.2)     (31.2)            
Stock Issued During Period, Shares, Issued for Services               13      
Stock Issued During Period, Value, Issued for Services 2.9 2.9     2.9            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               20      
Stock Issued During Period, Value, Employee Stock Purchase Plan 4.4 4.4     4.4            
Stock-based compensation 56.6 56.6     56.6            
Balance (in shares) at Sep. 30, 2021               358,574   3  
Balance at Sep. 30, 2021 27,282.1 21,207.4 6,037.4 37.3 27,282.1            
Balance at Sep. 30, 2021           0.0          
Balance (in shares) at Jun. 30, 2021               358,305   3  
Balance at Jun. 30, 2021 26,787.4 21,222.7 5,434.5 106.0 26,763.2            
Balance at Jun. 30, 2021           24.2          
Less: net (income) loss attributable to non-controlling interests 0.2         0.2          
Net Income Attributable to CME Group 926.5   926.5   926.5            
Net Income 926.3                    
Other comprehensive income (loss), net of tax (68.7)     (68.7) (68.7)            
Dividends, Cash (323.6)   (323.6)   (323.6)            
Purchase of noncontrolling interest (39.5) (15.5)     (15.5) 24.0          
Exercise of stock options, shares               43      
Exercise of stock options 2.3 2.3     2.3            
Vesting of issued restricted Class A common stock, shares               226      
Vesting of issued restricted Class A common stock (17.7) (17.7)     (17.7)            
Stock-based compensation 15.6 15.6     15.6            
Balance (in shares) at Sep. 30, 2021               358,574   3  
Balance at Sep. 30, 2021 27,282.1 21,207.4 6,037.4 37.3 27,282.1            
Balance at Sep. 30, 2021           $ 0.0          
Balance (in shares) at Dec. 31, 2021             358,599 358,599 3 3 4,584
Balance at Dec. 31, 2021 27,399.3 22,193.9 5,151.9 53.5 27,399.3            
Less: net (income) loss attributable to non-controlling interests 0.0                    
Net Income Attributable to CME Group 2,053.1   2,053.1   2,053.1            
Net Income 2,053.1                    
Other comprehensive income (loss), net of tax (153.3)     (153.3) (153.3)            
Dividends, Cash     (1,093.3)   (1,093.3)            
Exercise of stock options, shares               1      
Exercise of stock options   0.1     0.1            
Vesting of issued restricted Class A common stock, shares               239      
Vesting of issued restricted Class A common stock   (21.7)     (21.7)            
Stock Issued During Period, Shares, Issued for Services               19      
Stock Issued During Period, Value, Issued for Services   4.0     4.0            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               19      
Stock Issued During Period, Value, Employee Stock Purchase Plan   3.8     3.8            
Stock-based compensation   58.8     58.8            
Balance (in shares) at Sep. 30, 2022             358,877 358,877 3 3 4,584
Balance at Sep. 30, 2022 28,250.8 22,238.9 6,111.7 (99.8) 28,250.8            
Balance (in shares) at Jun. 30, 2022               358,677   3 4,584
Balance at Jun. 30, 2022   22,235.9 5,797.5 (31.7) 28,001.7            
Less: net (income) loss attributable to non-controlling interests 0.0                    
Net Income Attributable to CME Group 679.6   679.6   679.6            
Net Income 679.6                    
Other comprehensive income (loss), net of tax (68.1)     (68.1) (68.1)            
Dividends, Cash     (365.4)   (365.4)            
Vesting of issued restricted Class A common stock, shares               200      
Vesting of issued restricted Class A common stock   (16.4)     (16.4)            
Stock-based compensation   19.4     19.4            
Balance (in shares) at Sep. 30, 2022             358,877 358,877 3 3 4,584
Balance at Sep. 30, 2022 $ 28,250.8 $ 22,238.9 $ 6,111.7 $ (99.8) $ 28,250.8